![An interesting commentary on the interpretation of the Nilotinib trial results – The Science of Parkinson's An interesting commentary on the interpretation of the Nilotinib trial results – The Science of Parkinson's](https://scienceofpd.files.wordpress.com/2017/01/maoi-inhibitor.png)
An interesting commentary on the interpretation of the Nilotinib trial results – The Science of Parkinson's
![Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease | Journal of Pharmacology and Experimental Therapeutics Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/sites/default/files/highwire/jpet/362/3.cover-source.jpg)
Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease | Journal of Pharmacology and Experimental Therapeutics
![Selective MAO-B inhibition cannot produce an effective antidepressant... | Download Scientific Diagram Selective MAO-B inhibition cannot produce an effective antidepressant... | Download Scientific Diagram](https://www.researchgate.net/publication/23423713/figure/fig1/AS:667224079601664@1536090025036/Selective-MAO-B-inhibition-cannot-produce-an-effective-antidepressant-response.png)
Selective MAO-B inhibition cannot produce an effective antidepressant... | Download Scientific Diagram
![Identification of novel monoamine oxidase selective inhibitors employing a hierarchical ligand-based virtual screening strategy | Future Medicinal Chemistry Identification of novel monoamine oxidase selective inhibitors employing a hierarchical ligand-based virtual screening strategy | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc-2018-0596/asset/images/medium/figure1.gif)